Osaic Holdings
RNTX

Osaic Holdings’s Rein Therapeutics RNTX Stock Holding History

Osaic Holdings’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-70
Closed -$81 – 8128
2025
Q4 		$81 Buy
70
+35
+100% +$48 ﹤0.01% 7663
2025
Q3 		$40 Hold
35
– – ﹤0.01% 7796
2025
Q2 		$49 Sell
35
-105
-75% -$189 ﹤0.01% 7616
2025
Q1 		$248 Buy
+140
New +$294 ﹤0.01% 7136
2023
Q1 		– Sell
-3,656
Closed -$9K – 7585
2022
Q4 		$9K Buy
3,656
+333
+10% +$1.12K ﹤0.01% 6015
2022
Q3 		$14K Buy
3,323
+1,213
+57% +$5.12K ﹤0.01% 5843
2022
Q2 		$11K Buy
2,110
+80
+4% +$735 ﹤0.01% 6042
2022
Q1 		$21K Buy
2,030
+80
+4% +$724 ﹤0.01% 5668
2021
Q4 		$22K Buy
1,950
+1,119
+135% +$17.3K ﹤0.01% 5738
2021
Q3 		$17K Buy
831
+314
+61% +$6.88K ﹤0.01% 5897
2021
Q2 		$13K Buy
517
+253
+96% +$6.31K ﹤0.01% 5922
2021
Q1 		$8K Buy
264
+153
+138% +$5.24K ﹤0.01% 5993
2020
Q4 		$2K Buy
+111
New +$2.77K ﹤0.01% 6124

Other funds holding RNTX

VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Osaic Holdings's RNTX Position: Q1 2026 in Review

Osaic Holdings sold out of Rein Therapeutics (RNTX) in Q1 2026, closing a stake of 70 shares — an estimated $81 sold.

Osaic Holdings first reported a position in RNTX in Q4 2020 and held it in 13 quarters. The position peaked at $22K in Q4 2021. 46 funds tracked by Wall St. Rank hold RNTX as of Q1 2026.

  • Osaic Holdings reported no remaining Rein Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Osaic Holdings sold 70 Rein Therapeutics shares in Q1 2026, an estimated $81.
  • Osaic Holdings first reported a position in Rein Therapeutics in Q4 2020 and held it in 13 quarters.
  • Osaic Holdings's Rein Therapeutics position peaked at $22K in Q4 2021.
  • 46 funds tracked by Wall St. Rank held Rein Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.